Literature DB >> 31537530

The architecture of the IgG anti-carbohydrate repertoire in primary antibody deficiencies.

Peter Jandus1, Kayluz Frias Boligan2, David F Smith3, Elisabeth de Graauw2, Bodo Grimbacher4,5,6,7, Camilla Jandus2,8,9, Mai M Abdelhafez10, Alain Despont10, Nicolai Bovin11,12, Dagmar Simon13, Robert Rieben10, Hans-Uwe Simon2,14, Richard D Cummings3,15, Stephan von Gunten2.   

Abstract

Immune system failure in primary antibody deficiencies (PADs) has been linked to recurrent infections, autoimmunity, and cancer, yet clinical judgment is often based on the reactivity to a restricted panel of antigens. Previously, we demonstrated that the human repertoire of carbohydrate-specific immunoglobulin G (IgG) exhibits modular organization related to glycan epitope structure. The current study compares the glycan-specific IgG repertoires between different PAD entities. Distinct repertoire profiles with extensive qualitative glycan-recognition defects were observed, which are characterized by the common loss of Galα and GalNAc reactivity and disease-specific recognition of microbial antigens, self-antigens, and tumor-associated carbohydrate antigens. Antibody repertoire analysis may provide a useful tool to elucidate the degree and the clinical implications of immune system failure in individual patients.
© 2019 by The American Society of Hematology.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31537530      PMCID: PMC6887115          DOI: 10.1182/blood.2019001705

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  54 in total

Review 1.  Vaccines in the assessment of patients for immune deficiency.

Authors:  Mark Ballow
Journal:  J Allergy Clin Immunol       Date:  2012-07       Impact factor: 10.793

2.  The human IgG anti-carbohydrate repertoire exhibits a universal architecture and contains specificity for microbial attachment sites.

Authors:  Christoph Schneider; David F Smith; Richard D Cummings; Kayluz Frias Boligan; Robert G Hamilton; Bruce S Bochner; Sylvia Miescher; Hans-Uwe Simon; Anastas Pashov; Tchavdar Vassilev; Stephan von Gunten
Journal:  Sci Transl Med       Date:  2015-01-07       Impact factor: 17.956

3.  Morbidity and mortality in common variable immune deficiency over 4 decades.

Authors:  Elena S Resnick; Erin L Moshier; James H Godbold; Charlotte Cunningham-Rundles
Journal:  Blood       Date:  2011-12-16       Impact factor: 22.113

4.  Evidence for a role of eosinophils in blister formation in bullous pemphigoid.

Authors:  E de Graauw; C Sitaru; M Horn; L Borradori; S Yousefi; H-U Simon; D Simon
Journal:  Allergy       Date:  2017-03-01       Impact factor: 13.146

Review 5.  Microbial Dysbiosis in Common Variable Immune Deficiencies: Evidence, Causes, and Consequences.

Authors:  Roos-Marijn Berbers; Stefan Nierkens; Jacob M van Laar; Debby Bogaert; Helen L Leavis
Journal:  Trends Immunol       Date:  2016-12-22       Impact factor: 16.687

6.  Thomsen-Friedenreich antigen expression in gastric carcinomas is associated with MUC1 mucin VNTR polymorphism.

Authors:  F Santos-Silva; A Fonseca; T Caffrey; F Carvalho; P Mesquita; C Reis; R Almeida; L David; M A Hollingsworth
Journal:  Glycobiology       Date:  2004-12-15       Impact factor: 4.313

7.  Intravenous immunoglobulin contains a broad repertoire of anticarbohydrate antibodies that is not restricted to the IgG2 subclass.

Authors:  Stephan von Gunten; David F Smith; Richard D Cummings; Stefan Riedel; Sylvia Miescher; Alexander Schaub; Robert G Hamilton; Bruce S Bochner
Journal:  J Allergy Clin Immunol       Date:  2009-05-13       Impact factor: 10.793

Review 8.  Natural anti-carbohydrate antibodies contributing to evolutionary survival of primates in viral epidemics?

Authors:  Uri Galili
Journal:  Glycobiology       Date:  2016-08-27       Impact factor: 4.313

9.  Production of alpha 1,3-galactosyltransferase-deficient pigs.

Authors:  Carol J Phelps; Chihiro Koike; Todd D Vaught; Jeremy Boone; Kevin D Wells; Shu-Hung Chen; Suyapa Ball; Susan M Specht; Irina A Polejaeva; Jeff A Monahan; Pete M Jobst; Sugandha B Sharma; Ashley E Lamborn; Amy S Garst; Marilyn Moore; Anthony J Demetris; William A Rudert; Rita Bottino; Suzanne Bertera; Massimo Trucco; Thomas E Starzl; Yifan Dai; David L Ayares
Journal:  Science       Date:  2002-12-19       Impact factor: 47.728

Review 10.  Cancers Related to Immunodeficiencies: Update and Perspectives.

Authors:  Esmaeil Mortaz; Payam Tabarsi; Davod Mansouri; Adnan Khosravi; Johan Garssen; Aliakbar Velayati; Ian M Adcock
Journal:  Front Immunol       Date:  2016-09-20       Impact factor: 7.561

View more
  7 in total

1.  Glycosylation and Cardiovascular Diseases.

Authors:  Hesam Dashti; Maria Angelica Pabon Porras; Samia Mora
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 3.650

2.  Enhanced Pro-apoptotic Effects of Fe(II)-Modified IVIG on Human Neutrophils.

Authors:  Stefanie Graeter; Christoph Schneider; Daniëlle Verschoor; Sandro von Däniken; Frank Seibold; Nikhil Yawalkar; Peter Villiger; Jordan D Dimitrov; David F Smith; Richard D Cummings; Hans-Uwe Simon; Tchavdar Vassilev; Stephan von Gunten
Journal:  Front Immunol       Date:  2020-05-19       Impact factor: 7.561

3.  Expression signature, prognosis value, and immune characteristics of Siglec-15 identified by pan-cancer analysis.

Authors:  Baihui Li; Bailu Zhang; Xuezhou Wang; Ziqing Zeng; Ziqi Huang; Lin Zhang; Feng Wei; Xiubao Ren; Lili Yang
Journal:  Oncoimmunology       Date:  2020-08-28       Impact factor: 8.110

4.  Diagnostic Vaccination in Clinical Practice.

Authors:  Anette Tarp Hansen; Anna Söderström; Charlotte Sværke Jørgensen; Carsten Schade Larsen; Mikkel Steen Petersen; Jens Magnus Bernth Jensen
Journal:  Front Immunol       Date:  2021-09-30       Impact factor: 7.561

5.  Prognostic value of PD-L1 and Siglec-15 expression in patients with nasopharyngeal carcinoma.

Authors:  Ju Zhao; Hanshan Yang; Hui Hu; Chao Liu; Min Wei; Yumei Zhao; Yudan Chen; Yongxia Cui; Ping Chen; Kang Xiong; Yun Lu; Hongru Yang; Linglin Yang
Journal:  Sci Rep       Date:  2022-06-21       Impact factor: 4.996

6.  Xenogeneic Neu5Gc and self-glycan Neu5Ac epitopes are potential immune targets in MS.

Authors:  Kayluz F Boligan; Johanna Oechtering; Christian W Keller; Benjamin Peschke; Robert Rieben; Nicolai Bovin; Ludwig Kappos; Richard D Cummings; Jens Kuhle; Stephan von Gunten; Jan D Lünemann
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2020-02-03

7.  Unique repertoire of anti-carbohydrate antibodies in individual human serum.

Authors:  Ralph N D Luetscher; Tanya R McKitrick; Chao Gao; Akul Y Mehta; Alyssa M McQuillan; Robert Kardish; Kayluz Frias Boligan; Xuezheng Song; Lenette Lu; Jamie Heimburg-Molinaro; Stephan von Gunten; Galit Alter; Richard D Cummings
Journal:  Sci Rep       Date:  2020-09-22       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.